Aveanna Healthcare Holdings, INC 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

NASDAQ
Aveanna Healthcare Holdings Inc. announced a significant increase in revenue and net income for the second quarter ended July 4, 2026, driven by strong performance across its segments and strategic acquisitions.
NASDAQ
Aveanna Healthcare Holdings Inc. reported a significant increase in net income and revenue for the first quarter of 2026, driven by strong performance across its segments and a decrease in interest expenses.
NASDAQ
Aveanna Healthcare Holdings Inc. reported significant revenue and net income increases for Q3 2025, driven by acquisitions and improved rates, alongside a major debt refinancing.
NASDAQ
Aveanna Healthcare Holdings Inc. filed an amendment to its Q2 2025 report, disclosing the termination of a Rule 10b5-1 trading arrangement by the Whitney Funds for over 9 million shares and new sell-to-cover plans for officers.
NASDAQ
Aveanna Healthcare Holdings Inc. reported significant revenue and net income growth in Q2 2025, driven by strong performance across all segments and strategic acquisitions.
NASDAQ
Aveanna Healthcare Holdings Inc. announces a significant increase in net income and revenue for the first quarter of 2025, driven by growth in its Private Duty Services segment and improved operational efficiencies.
NASDAQ
Aveanna Healthcare Holdings Inc. reported improved financial results for the third quarter of 2024, driven by revenue growth across all segments and effective cost management.
NASDAQ
Aveanna Healthcare's second quarter saw a revenue increase of 7.0% year-over-year, but net income decreased by 45.7% due to various factors including increased costs and changes in interest rate derivatives.
NASDAQ
Aveanna Healthcare's first quarter 2024 results show a revenue increase and a significant reduction in net loss compared to the same period last year.